DexCom Stock Forecast - Daily Balance Of Power
| DXCM Stock | USD 80.24 0.70 0.88% |
DexCom Stock Forecast is based on your current time horizon.
DexCom |
| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| 0.2612 | 0.3036 |
| Check DexCom Volatility | Backtest DexCom | Trend Details |
DexCom Trading Date Momentum
| On December 26 2024 DexCom Inc was traded for 80.24 at the closing time. The top price for the day was 80.83 and the lowest listed price was 78.59 . There was no trading activity during the period 0.0. Lack of trading volume on December 26, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.85% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
| Compare DexCom to competition |
Other Forecasting Options for DexCom
For every potential investor in DexCom, whether a beginner or expert, DexCom's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. DexCom Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in DexCom. Basic forecasting techniques help filter out the noise by identifying DexCom's price trends.DexCom Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with DexCom stock to make a market-neutral strategy. Peer analysis of DexCom could also be used in its relative valuation, which is a method of valuing DexCom by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
DexCom Inc Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of DexCom's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of DexCom's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
DexCom Market Strength Events
Market strength indicators help investors to evaluate how DexCom stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading DexCom shares will generate the highest return on investment. By undertsting and applying DexCom stock market strength indicators, traders can identify DexCom Inc entry and exit signals to maximize returns.
DexCom Risk Indicators
The analysis of DexCom's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in DexCom's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting dexcom stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.55 | |||
| Semi Deviation | 1.46 | |||
| Standard Deviation | 2.1 | |||
| Variance | 4.43 | |||
| Downside Variance | 2.74 | |||
| Semi Variance | 2.12 | |||
| Expected Short fall | (1.78) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of DexCom to cross-verify your projections. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.157 | Earnings Share 1.65 | Revenue Per Share 10.089 | Quarterly Revenue Growth 0.02 | Return On Assets 0.0606 |
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.